[go: up one dir, main page]

TR200806302A2 - Çözünürlük ve stabilite artırıcı farmasötik formülasyon. - Google Patents

Çözünürlük ve stabilite artırıcı farmasötik formülasyon.

Info

Publication number
TR200806302A2
TR200806302A2 TR2008/06302A TR200806302A TR200806302A2 TR 200806302 A2 TR200806302 A2 TR 200806302A2 TR 2008/06302 A TR2008/06302 A TR 2008/06302A TR 200806302 A TR200806302 A TR 200806302A TR 200806302 A2 TR200806302 A2 TR 200806302A2
Authority
TR
Turkey
Prior art keywords
solubility
pharmaceutical formulation
stability enhancing
enhancing pharmaceutical
stability
Prior art date
Application number
TR2008/06302A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2008/06302A priority Critical patent/TR200806302A2/tr
Priority to PCT/TR2009/000109 priority patent/WO2010021609A1/en
Publication of TR200806302A2 publication Critical patent/TR200806302A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş, çözünürlük sorunu olan bir aktif maddeyi stabilite sorunu olan bir terapötik ajanla kombinasyon halinde içeren farmasötik formülasyonlara, bunların hazırlanma yöntemlerine ve tıbbi kullanımlarına ilişkindir.
TR2008/06302A 2008-08-22 2008-08-22 Çözünürlük ve stabilite artırıcı farmasötik formülasyon. TR200806302A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2008/06302A TR200806302A2 (tr) 2008-08-22 2008-08-22 Çözünürlük ve stabilite artırıcı farmasötik formülasyon.
PCT/TR2009/000109 WO2010021609A1 (en) 2008-08-22 2009-08-24 Solubility and stability enhancing pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2008/06302A TR200806302A2 (tr) 2008-08-22 2008-08-22 Çözünürlük ve stabilite artırıcı farmasötik formülasyon.

Publications (1)

Publication Number Publication Date
TR200806302A2 true TR200806302A2 (tr) 2010-03-22

Family

ID=41396995

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2008/06302A TR200806302A2 (tr) 2008-08-22 2008-08-22 Çözünürlük ve stabilite artırıcı farmasötik formülasyon.

Country Status (2)

Country Link
TR (1) TR200806302A2 (tr)
WO (1) WO2010021609A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011002424A2 (en) * 2009-07-02 2011-01-06 Bilgic Mahmut Solubility and stability enchancing pharmaceutical formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
WO2006134604A1 (en) * 2005-06-15 2006-12-21 Hetero Drugs Limited Combination composition of cholesterol absorption inhibitor and 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase inhibitor
EP1741427A1 (en) * 2005-07-06 2007-01-10 KRKA, D.D., Novo Mesto Pharmaceutical composition comprising simvastatin and ezetimibe
US20070202159A1 (en) * 2006-02-02 2007-08-30 Mathur Rajeev S Pharmaceutical composition comprising stabilized statin particles
EP2120882A2 (en) * 2007-02-23 2009-11-25 Krka Pharmaceutical composition containing a cholesterol absorption inhibitor

Also Published As

Publication number Publication date
WO2010021609A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
TR200806298A2 (tr) Farmasötik formülasyon
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
TR201809514T4 (tr) Uzun süre etkili insülin formülasyonları.
ECSP109917A (es) Nuevos derivados de ácido azabifenilaminobenzoico
CY2017018I2 (el) Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201390799A1 (ru) Триазолопиридины
TR200900878A2 (tr) Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
CY1117174T1 (el) ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
MX2009012782A (es) Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
UY31839A (es) Compuestos
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
JP2009292763A5 (tr)
TR200806302A2 (tr) Çözünürlük ve stabilite artırıcı farmasötik formülasyon.
TR201803451T4 (tr) Olmesartan formülasyonlari.
IN2014DN10134A (tr)
TR200806301A2 (tr) Çözünürlük ve stabilite artırıcı farmasötik formülasyon.
TR200806303A2 (tr) Çözünürlük ve stabililte artırıcı farmasötik formülasyon